Table 2

Predictive validity of candidate remission definitions for good outcome in adiographic damage*

Prevalence of good outcome in patients
Candidate remission definitionIn remissionNot in remissionPositive likelihood ratio (95% CI)p
TJC28, SJC28, CRP ≤169 (34/49)50 (154/306)2.0 (1.1 to 3.6)0.01
TJC28, SJC28, CRP, PhGA ≤176 (26/34)51 (162/320)2.9 (1.3 to 6.2)0.004
TJC28, SJC28, CRP, PtGA ≤177 (23/30)51 (165/325)2.9 (1.3 to 6.6)0.006
TJC28, SJC28, CRP, pain ≤174 (23/31)51 (165/324)2.6 (1.2 to 5.6)0.01
TJC28, SJC28, CRP, PhGA, PtGA ≤177 (20/26)51 (168/328)2.9 (1.2 to 7.2)0.01
TJC28, SJC28, CRP, PhGA, pain ≤177 (20/26)51 (168/328)2.9 (1.2 to 7.2)0.01
TJC28, SJC28, CRP, PtGA, pain ≤176 (22/29)51 (166/326)2.8 (1.2 to 6.4)0.001
TJC28, SJC28, CRP, PhGA, PtGA, pain ≤176 (19/25)51 (169/329)2.8 (1.1 to 6.8)0.02
DAS28 <2.660 (21/35)59 (93/157)1.0 (0.6 to 1.9)0.93
DAS28 <2.070 (7/10)59 (107/182)1.6 (0.4 to 6.0)0.48
SDAI ≤3.377 (27/35)50 (161/319)3.0 (1.4 to 6.4)0.003
Definitions without CRP (for clinical practice)
TJC28, SJC28, PhGA, PtGA ≤175 (24/32)51 (167/326)2.6 (1.2 to 5.7)0.01
TJC28, SJC28, PtGA ≤175 (27/36)51 (164/323)2.6 (1.3 to 5.4)0.007
CDAI ≤2.8§75 (27/36)51 (164/322)2.6 (1.3 to 5.4)0.006
  • * Values in the first two columns are percentages, with absolute proportions shown in parentheses. Presence or absence of remission, defined according to the given candidate definition, was measured at 6 months after baseline, using combined data from methotrexate-alone treatment groups in three trials37 40 41 (limited to patients with complete data over 2 years). Good radiographic outcome was defined as a change of ≤0 in Sharp/van der Heijde scores between 12 and 24 months after baseline. CRP is in mg/dl.

  • From χ2 analysis using logistic regression, in which the independent variable was remission (based on the given candidate definition) and the dependent variable was radiographic stability.

  • SDAI is the simple sum of the TJC (using 28 joints), SJC (using 28 joints), patient global assessment (0–10 scale), physician global assessment (0–10 scale), and CRP level (mg/dl).

  • § CDAI is the same as the SDAI, except CRP is not included.

  • CDAI, Clinical Disease Activity Index; CRP, C reactive protein; DAS28, 28-joint Disease Activity Score (see table 1 for other definitions); PhGA, physician/observer global assessment; PtGA, patient global assessment; SDAI, Simplified Disease Activity Index; SJC, swollen joint count; TJC, tender joint count.